← Back to all trials
Not Yet Recruiting
NCT07865559
Vaginal Lactobacillus for Postoperative Microecology and Mucosal Repair in MRKH Syndrome
Conditions: Mayer Rokitansky Kuster Hauser Syndrome
Sex: Female
Ages: 18 Years – 35 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 32
Sponsor: Obstetrics & Gynecology Hospital of Fudan University
Summary
This study is aimed to evaluate the promoting effects of vaginal Lactobacillus capsule on microecological reconstruction and mucosal repair of the neovagina after biological graft vaginoplasty in patients with MRKH syndrome, , through a randomized controlled trial (RCT).
Eligibility Criteria
Inclusion Criteria:
* Patients diagnosed with MRKH syndrome;
* Undergoing initial surgical treatment;
* Undergoing biological graft vaginoplasty;
* Age: 18-35 years;
* Voluntarily participating in this study, signing the informed consent form, with good compliance and cooperation with follow-up.
Exclusion Criteria:
* History of previous vaginoplasty or other related treatments;
* History of diabetes mellitus or systemic immune system diseases;
* Concurrent severe medical or surgical diseases that make the patient unable to tolerate drug therapy;
* Inability or unwillingness to sign the informed consent form;
* Inability or unwillingness to comply with the study requiremen.
Source: ClinicalTrials.gov (NCT07865559). StuddyBuddy aggregates publicly available trial information.
